Loading...

Biotin anti-mouse TER-119/Erythroid Cells Antibody Biotin anti-mouse TER-119/Erythroid Cells Antibody

Pricing & Availability
Clone
TER-119 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-76
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
TER-119_Biotin_TER-119_Antibody_FC_041713
C57BL/6 bone marrow cells were stained with biotinylated TER-119 (filled histogram) or biotinylated rat IgG2b, κ isotype control (open histogram) and then detected with Sav-PE.
  • TER-119_Biotin_TER-119_Antibody_FC_041713
    C57BL/6 bone marrow cells were stained with biotinylated TER-119 (filled histogram) or biotinylated rat IgG2b, κ isotype control (open histogram) and then detected with Sav-PE.
Compare all formats
Cat # Size Price Quantity Check Availability Save
116203 50 µg DKK280
Check Availability


Need larger quantities of this item?
Request Bulk Quote
116204 500 µg DKK785
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

The TER-119 antigen is a 52 kD glycophorin A-associated protein, also known as Ly-76. TER-119 is an erythroid-specific antigen expressed on early proerythroblasts to mature erythrocytes, but not on erythroid colony-forming cells (BFU-E, blast-forming unit erythroid, or CFU-E, colony-forming unit erythroid).

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Day-14 fetal liver cells from a C57BL/6 mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

The TER-119 antibody is useful for distinguishing erythrocytes and cells in the erythroid lineage. Additional reported applications (for the relevant formats) include: immunoprecipitation1, Western blotting1, complement-mediated cytotoxicity3, and immunohistochemical staining of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections. Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 116253-116258).

Application References
  1. Kina T, et al. 2000. Br. J. Haematol. 109:280. (IP, WB)
  2. Vannucchi AM, et al. 2000. Blood 95:2559.
  3. Maraskovsky E, et al. 1996. J. Exp. Med. 184:1953. (CMCD)
  4. Grisendi S, et al. 2005. Nature 437:147. (FC)
  5. Bourdeau A, et al. 2007. Blood 109:4220.
  6. Chappaz S, et al. 2007. Blood 110:3862. (FC)
  7. Heuser M, et al. 2007. Blood 110:1639. (FC)
  8. Gough SM, et al. 2014. Cancer Discov. 4:564. PubMed
Product Citations
  1. Drobek A, et al. 2015. J Immunol. 195: 3416 - 3426. PubMed
  2. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  3. Cox BS, et al. 2022. JCI Insight. 7: . PubMed
  4. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  5. Chanda MK, et al. 2022. J Immunol Methods. 506:113290. PubMed
  6. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  7. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  8. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  9. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  10. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  11. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  12. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  13. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  14. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  15. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  16. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  17. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  18. Gbyli R, et al. 2022. Leukemia. 36:1313. PubMed
  19. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  20. Yuan O, et al. 2022. Sci Adv. 8:eabm9987. PubMed
  21. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  22. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
  23. Rundberg Nilsson A, et al. 2023. iScience. 26:106341. PubMed
  24. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  25. Riffelmacher T, et al. 2023. Nat Cell Biol. 25:877. PubMed
  26. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  27. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  28. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  29. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  30. Wu J, et al. 2022. Nat Commun. 13:7321. PubMed
  31. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  32. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  33. Guo F, et al. 2022. Front Immunol. 13:833100. PubMed
  34. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  35. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  36. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  37. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  38. Geiger SS, et al. 2021. Nature Communications. 12(1):2745. PubMed
  39. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  40. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  41. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  42. Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed
  43. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  44. Tian M, et al. 2020. Proc Natl Acad Sci U S A. 117:7929. PubMed
  45. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  46. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  47. Krueger PD, et al. 2021. Immunity. 54(4):687-701.e4. PubMed
  48. Fu R, et al. 2019. Nat Commun. 10:3210. PubMed
  49. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  50. Hodzic D, et al. 2022. PLoS Biol. 20:e3001811. PubMed
  51. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  52. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  53. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  54. Iturri L, et al. 2021. Immunity. . PubMed
  55. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  56. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  57. Verena Sigl et al. 2017. Cell research. 26(7):761-74 . PubMed
  58. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  59. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  60. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  61. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  62. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  63. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  64. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  65. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  66. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  67. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  68. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  69. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  70. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  71. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  72. Liu YY, et al. 2020. Chin Med J (Engl). 133:1688. PubMed
  73. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  74. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  75. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  76. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  77. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  78. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  79. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  80. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  81. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  82. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  83. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  84. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  85. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  86. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  87. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  88. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  89. Chatterjee S, et al. 2014. PLoS One. 9:87858. PubMed
  90. Peraki I, Palis J, and Mavrothalassitis G. 2017. Mol Cell Biol. 10.1128/MCB.00183-17. PubMed
  91. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  92. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  93. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  94. Zhu H, et al. 2020. J Bone Miner Res. 35:698. PubMed
  95. Ludwik KA, et al. 2021. STAR Protocols. 2(1):100270. PubMed
  96. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  97. Dong S, et al. 2021. Nature. 591:117. PubMed
  98. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  99. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  100. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  101. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  102. Milner JJ, et al. 2020. Immunity. 52(5):808-824.e7. PubMed
  103. Lebert-Ghali C, et al. 2016. Blood. 127: 87-90. PubMed
  104. Sitaraman S, et al. 2019. Sci Rep. 9:12509. PubMed
  105. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  106. Lüönd F, et al. 2022. STAR Protoc. 3:101438. PubMed
  107. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  108. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  109. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  110. Wang C, et al. 2018. J Clin Invest. 128:3872. PubMed
  111. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  112. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  113. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  114. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  115. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  116. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  117. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  118. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  119. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  120. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  121. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  122. Kanemaru K, et al. 2015. PLoS One. 10: 0144436. PubMed
  123. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  124. Bagadia P, et al. 2019. Nat Immunol. 20:1174. PubMed
  125. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  126. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  127. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  128. Fujii T, et al. 2021. Bone Res. 9:4. PubMed
  129. Gu VW, et al. 2021. Stem Cell Reports. 16:106. PubMed
  130. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  131. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  132. Alexander K, et al. 2016. Immunol Cell Biol. 95:7-16. PubMed
  133. Hasenberg M, et al. 2011. PLoS One. 6:e17314. PubMed
  134. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  135. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  136. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  137. Buffolo M, et al. 2019. Cell Rep. 29:270. PubMed
  138. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  139. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  140. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  141. Christin JR, et al. 2020. Cell Reports. 31(10):107742. PubMed
  142. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  143. He M, et al. 2020. Cell Metabolism. 31(3):580-591. PubMed
  144. Wolock SL, et al. 2019. Cell Rep. 28:302. PubMed
  145. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  146. Koide S, et al. 2022. iScience. 25:103603. PubMed
  147. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  148. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  149. Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed
  150. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  151. Michel A, et al. 2013. J Immunol. 90:5534. PubMed
  152. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  153. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  154. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  155. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  156. Lefkopoulos S, et al. 2020. Immunity. 53(5):934-951.e9. PubMed
  157. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  158. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  159. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  160. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  161. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  162. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  163. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  164. Huang X, et al. 2021. Immunity. . PubMed
  165. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  166. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  167. Seong J, et al. 2018. Development. 145:14. PubMed
  168. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  169. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  170. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
  171. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  172. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  173. Young K, et al. 2021. Cell Stem Cell. . PubMed
  174. Drobek A, et al. 2015. J Immunol. 195: 3416 - 3426. PubMed
  175. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  176. Cox BS, et al. 2022. JCI Insight. 7: . PubMed
  177. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  178. Chanda MK, et al. 2022. J Immunol Methods. 506:113290. PubMed
  179. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  180. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  181. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  182. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  183. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  184. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  185. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  186. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  187. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  188. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  189. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  190. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  191. Gbyli R, et al. 2022. Leukemia. 36:1313. PubMed
  192. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  193. Yuan O, et al. 2022. Sci Adv. 8:eabm9987. PubMed
  194. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  195. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
  196. Rundberg Nilsson A, et al. 2023. iScience. 26:106341. PubMed
  197. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  198. Riffelmacher T, et al. 2023. Nat Cell Biol. 25:877. PubMed
  199. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  200. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  201. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  202. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  203. Wu J, et al. 2022. Nat Commun. 13:7321. PubMed
  204. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  205. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  206. Guo F, et al. 2022. Front Immunol. 13:833100. PubMed
  207. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  208. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  209. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  210. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  211. Geiger SS, et al. 2021. Nature Communications. 12(1):2745. PubMed
  212. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  213. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  214. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  215. Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed
  216. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  217. Tian M, et al. 2020. Proc Natl Acad Sci U S A. 117:7929. PubMed
  218. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  219. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  220. Krueger PD, et al. 2021. Immunity. 54(4):687-701.e4. PubMed
  221. Fu R, et al. 2019. Nat Commun. 10:3210. PubMed
  222. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  223. Hodzic D, et al. 2022. PLoS Biol. 20:e3001811. PubMed
  224. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  225. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  226. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  227. Iturri L, et al. 2021. Immunity. . PubMed
  228. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  229. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  230. Verena Sigl et al. 2017. Cell research. 26(7):761-74 . PubMed
  231. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  232. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  233. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  234. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  235. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  236. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  237. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  238. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  239. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  240. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  241. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  242. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  243. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  244. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  245. Liu YY, et al. 2020. Chin Med J (Engl). 133:1688. PubMed
  246. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  247. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  248. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  249. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  250. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  251. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  252. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  253. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  254. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  255. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  256. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  257. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  258. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  259. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  260. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  261. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  262. Chatterjee S, et al. 2014. PLoS One. 9:87858. PubMed
  263. Peraki I, Palis J, and Mavrothalassitis G. 2017. Mol Cell Biol. 10.1128/MCB.00183-17. PubMed
  264. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  265. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  266. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  267. Zhu H, et al. 2020. J Bone Miner Res. 35:698. PubMed
  268. Ludwik KA, et al. 2021. STAR Protocols. 2(1):100270. PubMed
  269. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  270. Dong S, et al. 2021. Nature. 591:117. PubMed
  271. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  272. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  273. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  274. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  275. Milner JJ, et al. 2020. Immunity. 52(5):808-824.e7. PubMed
  276. Lebert-Ghali C, et al. 2016. Blood. 127: 87-90. PubMed
  277. Sitaraman S, et al. 2019. Sci Rep. 9:12509. PubMed
  278. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  279. Lüönd F, et al. 2022. STAR Protoc. 3:101438. PubMed
  280. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  281. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  282. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  283. Wang C, et al. 2018. J Clin Invest. 128:3872. PubMed
  284. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  285. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  286. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  287. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  288. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  289. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  290. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  291. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  292. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  293. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  294. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  295. Kanemaru K, et al. 2015. PLoS One. 10: 0144436. PubMed
  296. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  297. Bagadia P, et al. 2019. Nat Immunol. 20:1174. PubMed
  298. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  299. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  300. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  301. Fujii T, et al. 2021. Bone Res. 9:4. PubMed
  302. Gu VW, et al. 2021. Stem Cell Reports. 16:106. PubMed
  303. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  304. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  305. Alexander K, et al. 2016. Immunol Cell Biol. 95:7-16. PubMed
  306. Hasenberg M, et al. 2011. PLoS One. 6:e17314. PubMed
  307. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  308. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  309. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  310. Buffolo M, et al. 2019. Cell Rep. 29:270. PubMed
  311. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  312. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  313. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  314. Christin JR, et al. 2020. Cell Reports. 31(10):107742. PubMed
  315. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  316. He M, et al. 2020. Cell Metabolism. 31(3):580-591. PubMed
  317. Wolock SL, et al. 2019. Cell Rep. 28:302. PubMed
  318. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  319. Koide S, et al. 2022. iScience. 25:103603. PubMed
  320. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  321. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  322. Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed
  323. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  324. Michel A, et al. 2013. J Immunol. 90:5534. PubMed
  325. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  326. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  327. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  328. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  329. Lefkopoulos S, et al. 2020. Immunity. 53(5):934-951.e9. PubMed
  330. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  331. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  332. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  333. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  334. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  335. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  336. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  337. Huang X, et al. 2021. Immunity. . PubMed
  338. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  339. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  340. Seong J, et al. 2018. Development. 145:14. PubMed
  341. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  342. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  343. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
  344. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  345. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  346. Young K, et al. 2021. Cell Stem Cell. . PubMed
RRID
AB_313704 (BioLegend Cat. No. 116203)
AB_313705 (BioLegend Cat. No. 116204)

Antigen Details

Structure
Associated with glycophorin A, 52 kD
Distribution

Early proerythroblast to mature erythrocyte, but not BFU-E and CFU-E

Cell Type
Erythrocytes
Biology Area
Immunology
Antigen References

1. Kina T, et al. 2000. Br. J. Haematol. 109:280.
2. Ikuta K, et al. 1990. Cell 62:863.
3. Osawa M, et al. 1996. Weir's Handbook of Experimental Immunology. Vol. 2 pp. 66.1-66.5.

Gene ID
104231 View all products for this Gene ID

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All TER-119 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse TER-119/Erythroid Cells TER-119 FC
Purified anti-mouse TER-119/Erythroid Cells (Maxpar® Ready) TER-119 FC,CyTOF®
Purified anti-mouse TER-119/Erythroid Cells TER-119 FC,IHC-F,IHC-P,IP,WB
PE/Cyanine5 anti-mouse TER-119/Erythroid Cells TER-119 FC
PE anti-mouse TER-119/Erythroid Cells TER-119 FC
FITC anti-mouse TER-119/Erythroid Cells TER-119 FC
Biotin anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Dazzle™ 594 anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 785™ anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-A0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
APC/Fire™ 750 anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-B0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
TotalSeq™-C0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
Ultra-LEAF™ Purified anti-mouse TER-119/Erythroid Cells TER-119 FC,IHC-F,IHC-P,IP,WB,CMCD
Spark Blue™ 550 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Fire™ 810 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 647 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 488 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 700 anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP/Cyanine5.5 anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 421™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Pacific Blue™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 650™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 510™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 605™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Spark NIR™ 685 anti-mouse TER-119/Erythroid Cells Antibody TER-119 FC
Brilliant Violet 711™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Spark Red™ 718 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Spark Blue™ 574 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Spark YG™ 581 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Spark YG™ 593 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) Antibody TER-119 FC
Spark UV™ 387 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Spark PLUS UV395™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Go To Top Version: 3    Revision Date: 12/04/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
TER-119 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-76
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
TER-119_Biotin_TER-119_Antibody_FC_041713
C57BL/6 bone marrow cells were stained with biotinylated TER-119 (filled histogram) or biotinylated rat IgG2b, κ isotype control (open histogram) and then detected with Sav-PE.
  • TER-119_Biotin_TER-119_Antibody_FC_041713
    C57BL/6 bone marrow cells were stained with biotinylated TER-119 (filled histogram) or biotinylated rat IgG2b, κ isotype control (open histogram) and then detected with Sav-PE.
Compare all formats
Cat # Size Price Quantity Check Availability Save
116203 50 µg DKK280
Check Availability


Need larger quantities of this item?
Request Bulk Quote
116204 500 µg DKK785
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

The TER-119 antigen is a 52 kD glycophorin A-associated protein, also known as Ly-76. TER-119 is an erythroid-specific antigen expressed on early proerythroblasts to mature erythrocytes, but not on erythroid colony-forming cells (BFU-E, blast-forming unit erythroid, or CFU-E, colony-forming unit erythroid).

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Day-14 fetal liver cells from a C57BL/6 mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

The TER-119 antibody is useful for distinguishing erythrocytes and cells in the erythroid lineage. Additional reported applications (for the relevant formats) include: immunoprecipitation1, Western blotting1, complement-mediated cytotoxicity3, and immunohistochemical staining of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections. Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 116253-116258).

Application References
  1. Kina T, et al. 2000. Br. J. Haematol. 109:280. (IP, WB)
  2. Vannucchi AM, et al. 2000. Blood 95:2559.
  3. Maraskovsky E, et al. 1996. J. Exp. Med. 184:1953. (CMCD)
  4. Grisendi S, et al. 2005. Nature 437:147. (FC)
  5. Bourdeau A, et al. 2007. Blood 109:4220.
  6. Chappaz S, et al. 2007. Blood 110:3862. (FC)
  7. Heuser M, et al. 2007. Blood 110:1639. (FC)
  8. Gough SM, et al. 2014. Cancer Discov. 4:564. PubMed
Product Citations
  1. Drobek A, et al. 2015. J Immunol. 195: 3416 - 3426. PubMed
  2. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  3. Cox BS, et al. 2022. JCI Insight. 7: . PubMed
  4. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  5. Chanda MK, et al. 2022. J Immunol Methods. 506:113290. PubMed
  6. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  7. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  8. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  9. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  10. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  11. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  12. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  13. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  14. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  15. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  16. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  17. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  18. Gbyli R, et al. 2022. Leukemia. 36:1313. PubMed
  19. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  20. Yuan O, et al. 2022. Sci Adv. 8:eabm9987. PubMed
  21. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  22. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
  23. Rundberg Nilsson A, et al. 2023. iScience. 26:106341. PubMed
  24. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  25. Riffelmacher T, et al. 2023. Nat Cell Biol. 25:877. PubMed
  26. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  27. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  28. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  29. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  30. Wu J, et al. 2022. Nat Commun. 13:7321. PubMed
  31. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  32. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  33. Guo F, et al. 2022. Front Immunol. 13:833100. PubMed
  34. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  35. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  36. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  37. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  38. Geiger SS, et al. 2021. Nature Communications. 12(1):2745. PubMed
  39. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  40. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  41. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  42. Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed
  43. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  44. Tian M, et al. 2020. Proc Natl Acad Sci U S A. 117:7929. PubMed
  45. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  46. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  47. Krueger PD, et al. 2021. Immunity. 54(4):687-701.e4. PubMed
  48. Fu R, et al. 2019. Nat Commun. 10:3210. PubMed
  49. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  50. Hodzic D, et al. 2022. PLoS Biol. 20:e3001811. PubMed
  51. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  52. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  53. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  54. Iturri L, et al. 2021. Immunity. . PubMed
  55. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  56. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  57. Verena Sigl et al. 2017. Cell research. 26(7):761-74 . PubMed
  58. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  59. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  60. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  61. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  62. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  63. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  64. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  65. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  66. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  67. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  68. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  69. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  70. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  71. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  72. Liu YY, et al. 2020. Chin Med J (Engl). 133:1688. PubMed
  73. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  74. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  75. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  76. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  77. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  78. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  79. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  80. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  81. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  82. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  83. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  84. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  85. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  86. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  87. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  88. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  89. Chatterjee S, et al. 2014. PLoS One. 9:87858. PubMed
  90. Peraki I, Palis J, and Mavrothalassitis G. 2017. Mol Cell Biol. 10.1128/MCB.00183-17. PubMed
  91. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  92. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  93. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  94. Zhu H, et al. 2020. J Bone Miner Res. 35:698. PubMed
  95. Ludwik KA, et al. 2021. STAR Protocols. 2(1):100270. PubMed
  96. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  97. Dong S, et al. 2021. Nature. 591:117. PubMed
  98. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  99. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  100. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  101. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  102. Milner JJ, et al. 2020. Immunity. 52(5):808-824.e7. PubMed
  103. Lebert-Ghali C, et al. 2016. Blood. 127: 87-90. PubMed
  104. Sitaraman S, et al. 2019. Sci Rep. 9:12509. PubMed
  105. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  106. Lüönd F, et al. 2022. STAR Protoc. 3:101438. PubMed
  107. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  108. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  109. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  110. Wang C, et al. 2018. J Clin Invest. 128:3872. PubMed
  111. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  112. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  113. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  114. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  115. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  116. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  117. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  118. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  119. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  120. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  121. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  122. Kanemaru K, et al. 2015. PLoS One. 10: 0144436. PubMed
  123. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  124. Bagadia P, et al. 2019. Nat Immunol. 20:1174. PubMed
  125. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  126. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  127. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  128. Fujii T, et al. 2021. Bone Res. 9:4. PubMed
  129. Gu VW, et al. 2021. Stem Cell Reports. 16:106. PubMed
  130. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  131. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  132. Alexander K, et al. 2016. Immunol Cell Biol. 95:7-16. PubMed
  133. Hasenberg M, et al. 2011. PLoS One. 6:e17314. PubMed
  134. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  135. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  136. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  137. Buffolo M, et al. 2019. Cell Rep. 29:270. PubMed
  138. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  139. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  140. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  141. Christin JR, et al. 2020. Cell Reports. 31(10):107742. PubMed
  142. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  143. He M, et al. 2020. Cell Metabolism. 31(3):580-591. PubMed
  144. Wolock SL, et al. 2019. Cell Rep. 28:302. PubMed
  145. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  146. Koide S, et al. 2022. iScience. 25:103603. PubMed
  147. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  148. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  149. Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed
  150. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  151. Michel A, et al. 2013. J Immunol. 90:5534. PubMed
  152. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  153. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  154. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  155. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  156. Lefkopoulos S, et al. 2020. Immunity. 53(5):934-951.e9. PubMed
  157. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  158. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  159. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  160. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  161. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  162. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  163. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  164. Huang X, et al. 2021. Immunity. . PubMed
  165. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  166. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  167. Seong J, et al. 2018. Development. 145:14. PubMed
  168. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  169. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  170. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
  171. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  172. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  173. Young K, et al. 2021. Cell Stem Cell. . PubMed
  174. Drobek A, et al. 2015. J Immunol. 195: 3416 - 3426. PubMed
  175. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  176. Cox BS, et al. 2022. JCI Insight. 7: . PubMed
  177. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  178. Chanda MK, et al. 2022. J Immunol Methods. 506:113290. PubMed
  179. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  180. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  181. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  182. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  183. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  184. Theofilatos D, et al. 2022. STAR Protoc. 3:101839. PubMed
  185. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  186. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  187. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  188. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  189. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  190. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  191. Gbyli R, et al. 2022. Leukemia. 36:1313. PubMed
  192. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  193. Yuan O, et al. 2022. Sci Adv. 8:eabm9987. PubMed
  194. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  195. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
  196. Rundberg Nilsson A, et al. 2023. iScience. 26:106341. PubMed
  197. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  198. Riffelmacher T, et al. 2023. Nat Cell Biol. 25:877. PubMed
  199. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  200. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  201. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  202. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  203. Wu J, et al. 2022. Nat Commun. 13:7321. PubMed
  204. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  205. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  206. Guo F, et al. 2022. Front Immunol. 13:833100. PubMed
  207. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  208. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  209. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  210. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  211. Geiger SS, et al. 2021. Nature Communications. 12(1):2745. PubMed
  212. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  213. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  214. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  215. Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed
  216. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  217. Tian M, et al. 2020. Proc Natl Acad Sci U S A. 117:7929. PubMed
  218. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  219. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  220. Krueger PD, et al. 2021. Immunity. 54(4):687-701.e4. PubMed
  221. Fu R, et al. 2019. Nat Commun. 10:3210. PubMed
  222. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  223. Hodzic D, et al. 2022. PLoS Biol. 20:e3001811. PubMed
  224. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  225. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  226. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  227. Iturri L, et al. 2021. Immunity. . PubMed
  228. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  229. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  230. Verena Sigl et al. 2017. Cell research. 26(7):761-74 . PubMed
  231. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  232. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  233. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  234. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  235. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  236. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  237. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  238. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  239. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  240. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  241. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  242. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  243. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  244. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  245. Liu YY, et al. 2020. Chin Med J (Engl). 133:1688. PubMed
  246. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  247. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  248. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  249. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  250. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  251. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  252. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  253. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  254. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  255. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  256. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  257. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  258. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  259. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  260. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  261. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  262. Chatterjee S, et al. 2014. PLoS One. 9:87858. PubMed
  263. Peraki I, Palis J, and Mavrothalassitis G. 2017. Mol Cell Biol. 10.1128/MCB.00183-17. PubMed
  264. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  265. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  266. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  267. Zhu H, et al. 2020. J Bone Miner Res. 35:698. PubMed
  268. Ludwik KA, et al. 2021. STAR Protocols. 2(1):100270. PubMed
  269. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  270. Dong S, et al. 2021. Nature. 591:117. PubMed
  271. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  272. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  273. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  274. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  275. Milner JJ, et al. 2020. Immunity. 52(5):808-824.e7. PubMed
  276. Lebert-Ghali C, et al. 2016. Blood. 127: 87-90. PubMed
  277. Sitaraman S, et al. 2019. Sci Rep. 9:12509. PubMed
  278. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  279. Lüönd F, et al. 2022. STAR Protoc. 3:101438. PubMed
  280. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  281. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  282. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  283. Wang C, et al. 2018. J Clin Invest. 128:3872. PubMed
  284. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  285. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  286. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  287. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  288. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  289. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  290. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  291. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  292. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  293. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  294. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  295. Kanemaru K, et al. 2015. PLoS One. 10: 0144436. PubMed
  296. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  297. Bagadia P, et al. 2019. Nat Immunol. 20:1174. PubMed
  298. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  299. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  300. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  301. Fujii T, et al. 2021. Bone Res. 9:4. PubMed
  302. Gu VW, et al. 2021. Stem Cell Reports. 16:106. PubMed
  303. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  304. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  305. Alexander K, et al. 2016. Immunol Cell Biol. 95:7-16. PubMed
  306. Hasenberg M, et al. 2011. PLoS One. 6:e17314. PubMed
  307. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  308. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  309. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  310. Buffolo M, et al. 2019. Cell Rep. 29:270. PubMed
  311. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  312. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  313. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  314. Christin JR, et al. 2020. Cell Reports. 31(10):107742. PubMed
  315. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  316. He M, et al. 2020. Cell Metabolism. 31(3):580-591. PubMed
  317. Wolock SL, et al. 2019. Cell Rep. 28:302. PubMed
  318. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  319. Koide S, et al. 2022. iScience. 25:103603. PubMed
  320. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  321. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  322. Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed
  323. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  324. Michel A, et al. 2013. J Immunol. 90:5534. PubMed
  325. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  326. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  327. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  328. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  329. Lefkopoulos S, et al. 2020. Immunity. 53(5):934-951.e9. PubMed
  330. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  331. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  332. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  333. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  334. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  335. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  336. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  337. Huang X, et al. 2021. Immunity. . PubMed
  338. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  339. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  340. Seong J, et al. 2018. Development. 145:14. PubMed
  341. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  342. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  343. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
  344. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  345. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  346. Young K, et al. 2021. Cell Stem Cell. . PubMed
RRID
AB_313704 (BioLegend Cat. No. 116203)
AB_313705 (BioLegend Cat. No. 116204)

Antigen Details

Structure
Associated with glycophorin A, 52 kD
Distribution

Early proerythroblast to mature erythrocyte, but not BFU-E and CFU-E

Cell Type
Erythrocytes
Biology Area
Immunology
Antigen References

1. Kina T, et al. 2000. Br. J. Haematol. 109:280.
2. Ikuta K, et al. 1990. Cell 62:863.
3. Osawa M, et al. 1996. Weir's Handbook of Experimental Immunology. Vol. 2 pp. 66.1-66.5.

Gene ID
104231 View all products for this Gene ID

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All TER-119 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse TER-119/Erythroid Cells TER-119 FC
Purified anti-mouse TER-119/Erythroid Cells (Maxpar® Ready) TER-119 FC,CyTOF®
Purified anti-mouse TER-119/Erythroid Cells TER-119 FC,IHC-F,IHC-P,IP,WB
PE/Cyanine5 anti-mouse TER-119/Erythroid Cells TER-119 FC
PE anti-mouse TER-119/Erythroid Cells TER-119 FC
FITC anti-mouse TER-119/Erythroid Cells TER-119 FC
Biotin anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Dazzle™ 594 anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 785™ anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-A0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
APC/Fire™ 750 anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-B0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
TotalSeq™-C0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
Ultra-LEAF™ Purified anti-mouse TER-119/Erythroid Cells TER-119 FC,IHC-F,IHC-P,IP,WB,CMCD
Spark Blue™ 550 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Fire™ 810 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 647 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 488 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 700 anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP/Cyanine5.5 anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 421™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Pacific Blue™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 650™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 510™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 605™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Spark NIR™ 685 anti-mouse TER-119/Erythroid Cells Antibody TER-119 FC
Brilliant Violet 711™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Spark Red™ 718 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Spark Blue™ 574 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Spark YG™ 581 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Spark YG™ 593 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) Antibody TER-119 FC
Spark UV™ 387 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Spark PLUS UV395™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Go To Top Version: 3    Revision Date: 12/04/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account